Developer docs
API playgroundTry for free, no card

Search company profiles

Antech Diagnostics

Full company profile

uuid0009xxu

Namestring
Antech Diagnostics
Legal namestring
Antech Diagnostics, Inc
Company typeenum
Private
Founded yearint
1994
Descriptiontext

Antech Diagnostics, Inc. is a US-based veterinary diagnostics company and wholly-owned subsidiary of Mars, Incorporated, operating within Mars Petcare's Science & Diagnostics division. The company is positioned as North America's largest veterinary reference laboratory network and serves veterinary practices across the United States, Canada, the United Kingdom, and additional European markets. Its offering is a fully integrated diagnostic ecosystem combining reference laboratory send-out testing, in-house bench-top and handheld analyzers (Element series, trūRapid, Eurolyser Cube, scil Vet abc Plus+), Sound-branded imaging equipment (ultrasound, digital radiography, CT, C-Arm, laser therapy), AI-powered radiology interpretation (RapidRead, RapidRead Dental), proprietary specialty tests (KeyScreen GI Parasite PCR, CADET BRAF, Nu.Q, Allercept, FIRSTract), and access to 130+ board-certified pathologists and 50+ specialists for consultation.

The business operates across multiple revenue streams: recurring reference lab per-test fees (with completion and recheck codes), hardware sales plus consumables for in-house analyzers, imaging equipment sales and service subscriptions, and Allercept custom immunotherapy formulations. Distribution is direct-to-practice via dedicated phone support, account managers, and the HealthTracks cloud platform for ordering, results, and patient data management. Product innovation is concentrated in AI-enabled imaging interpretation and proprietary molecular diagnostics, with sustained launch cadence through 2025 and into 2026.

The company is privately held and does not disclose revenue. Its strategic trajectory has been defined by a series of parent-funded acquisitions — EUROLyser (2022), Heska Corporation at approximately $1.3 billion (2023), SYNLAB.vet GmbH (2023), and Cerba HealthCare (2025) — alongside geographic expansion into the UK and Europe, positioning Mars Science & Diagnostics as a global consolidator in veterinary laboratory services and in-clinic diagnostics.

Short descriptiontext

Antech Diagnostics is a privately held US veterinary diagnostics company and subsidiary of Mars, Incorporated, operating North America's largest veterinary reference lab network. It serves veterinary practices with reference lab testing, in-house analyzers, Sound imaging equipment, AI radiology interpretation, and specialist consultation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary reference laboratory, veterinary diagnostic testing, animal health diagnostics, veterinary imaging equipment, in-clinic diagnostic analyzers
Industry5 codes
1Reference Laboratory Testing (Clinical Pathology & Chemistry)
CodeHLAMADAAPrimaryYes
2Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers)
CodeHLAMADAIPrimaryNo
3Veterinary Anatomic Pathology (Histopathology & Cytology)
CodeHLAMADABPrimaryNo
4Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology)
CodeHLAMADACPrimaryNo
5Imaging/Lab Integration & Results Management (PACS, LIS Connectivity, Reporting)
CodeHLAMAGAKPrimaryNo
NAICS code4 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Veterinary Services54194
  • Analytical Laboratory Instrument Manufacturing334516
SIC code3 codes
  • Services-Medical Laboratories8071
  • Surgical & Medical Instruments & Apparatus3841
  • Laboratory Analytical Instruments3826
Product category
Veterinary Diagnostic Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Reference Laboratory Testing Services
TypeSubscription Recurring
Description

Send-out diagnostic testing services to veterinary practices across North America. Provides comprehensive testing including chemistry, hematology, pathology, microbiology, molecular diagnostics, and specialized panels. Revenue generated through per-test fees with completion codes and recheck codes at reduced pricing for ongoing patient monitoring.

antechdiagnostics.com
2In-House Diagnostic Equipment Sales
TypeHardware Sales
Description

Sale of bench-top and handheld analyzers including Element series (DCX, HT5+, HT5, i+, POC), HeskaView telecytology systems, trūRapid rapid tests, and related consumables. Equipment sold to veterinary clinics for in-practice testing with ongoing consumable revenue.

antechdiagnostics.com
3Imaging Equipment and Services
TypeHardware Sales
Description

Sale and service of diagnostic imaging equipment including digital radiography, ultrasound, CT, and therapeutic lasers through Sound brand. Additionally provides teleradiology and RapidRead AI interpretation services as ongoing subscription.

antechdiagnostics.com
4Allercept Immunotherapy Products
TypeLicensing Royalties
Description

Custom immunotherapy treatments (shots and drops) manufactured based on individual patient allergy testing results. Revenue from allergen-specific immunotherapy formulations for dogs, cats, and horses.

antechdiagnostics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 14 records shown
1RapidRead™
Description

AI-powered radiology interpretation tool for veterinary radiographs, including tooth-by-tooth dental analysis.

antechdiagnostics.com
+13 more records
Core offering1 text field

Antech Diagnostics operates North America's largest veterinary reference laboratory network, providing send-out diagnostic testing across chemistry, hematology, pathology, microbiology, molecular diagnostics, cancer screening, and allergy panels. The company complements this with a portfolio of in-clinic diagnostic analyzers and rapid tests (Element series, trūRapid series, Eurolyser Cube), AI-powered imaging interpretation (RapidRead and RapidRead Dental), Sound-branded imaging equipment, board-certified specialist consultation across nine disciplines, and the HealthTracks cloud platform for test ordering and results delivery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 98% overall agreement with reference lab methods for trūRapid FOUR vector-borne disease screening
+4 more records
Product and service15 records
1Reference Laboratory Testing Services
CategoryReference Laboratory Services
Description

North America's largest veterinary reference laboratory network providing send-out diagnostic testing including chemistry, hematology, pathology, microbiology, molecular diagnostics, and specialized panels to veterinary practices with 24-48 hour turnaround for most tests.

2KeyScreen GI Parasite PCR
CategoryReference Laboratory Diagnostics
Description

Cutting-edge gastrointestinal parasite PCR test using proprietary technology to identify parasite genetic material in fecal samples from dogs and cats, detecting 20 intestinal parasites, benzimidazole resistance in hookworms, and zoonotic potential of Giardia.

3Accuplex
CategoryReference Laboratory Diagnostics
Description

Multiplexed canine vector-borne disease screening test detecting heartworm antigen and antibodies for tick-borne diseases, with results typically available by 8:00 am the next day.

4Canine Cancer Diagnostics (CADET BRAF and Nu.Q)
CategoryReference Laboratory Diagnostics
Description

Reference laboratory cancer screening tests including CADET BRAF mutation detection for early canine bladder/prostate cancer (TCC/UC) and Nu.Q measurement of plasma nucleosome concentration for lymphoma and hemangiosarcoma detection.

5Allercept Allergy Testing and Immunotherapy
CategoryAllergy Diagnostics and Therapy
Description

Serum allergy testing using patented IgE detection technology sensitive to 10 picograms, combined with custom immunotherapy treatments (shots and drops) manufactured for individual patients with 50-80% positive response rates reported.

6Element Series In-House Diagnostic Analyzers
CategoryIn-House Diagnostic Equipment
Description

Bench-top and handheld in-clinic diagnostic analyzers including Element i+, DCX, HT5+, HT5, DC5X, AIM, COAG+, and POC for chemistry, hematology, blood gas, and coagulation testing, plus Element i+ SDMA testing for kidney function assessment added in January 2026.

7trūRapid In-House Test Series
CategoryIn-House Diagnostic Tests
Description

Rapid in-clinic immunodiagnostic tests including trūRapid FOUR for heartworm antigen, Lyme C6 antibody, Anaplasma, and Ehrlichia; plus Heartworm, HW/Lyme, and FIV/FeLV tests with room temperature storage and no refrigeration required.

8Sound Imaging Equipment
CategoryImaging Equipment
Description

Diagnostic imaging equipment line sold under the Sound brand including digital radiography, ultrasound, CT, C-arm, and therapeutic laser systems for veterinary practices, with installation, training, and demo support.

9RapidRead AI Radiology Interpretation
CategoryImaging Services
Description

AI-powered radiology interpretation service combining computer vision analysis with board-certified veterinary radiologist overread for enhanced diagnostic confidence on general radiographs.

10RapidRead Dental
CategoryImaging Services
Description

AI-powered computer vision tool delivering tooth-by-tooth analysis of veterinary intraoral dental radiographs in approximately 10 minutes, with a feline-specific version launched January 2026 addressing small tooth size and high tooth resorption prevalence.

11PennHIP
CategoryImaging Services
Description

Hip joint laxity measurement service used to estimate risk of canine osteoarthritis, with online training and a locator service for PennHIP-certified veterinarians.

12HeskaView Telecytology
CategoryTelemedicine and Software
Description

Telecytology service providing digital cytology consultations and practice information management system (PIMS) software solutions for veterinary practices.

13HealthTracks Platform
CategorySoftware Platform
Description

Cloud-based platform for ordering diagnostic tests, accessing laboratory and imaging results, and managing patient data, available via web and mobile with self-service onboarding for veterinary practices.

14Consultation Services
CategorySpecialist Consultation
Description

Peer-to-peer expert medical consultation services from 50+ board-certified specialists across nine disciplines, providing veterinary practices with specialist support on complex cases.

15Loved for Life by Antech
CategoryWellness Program
Description

Preventive care wellness program offering comprehensive diagnostic profiles designed to support lifelong pet health monitoring.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-04-21
Description

Antech launched the Antech Veterinary Futures Scholarship in partnership with Vet Set Go to support aspiring veterinary professionals. The scholarship invests in students to ensure pets receive quality care, coinciding with World Veterinary Day 2026.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-01-01
Description

Mars acquisitions of Cerba HealthCare to consolidate presence in clinical pathology markets as part of Mars Science & Diagnostics expansion.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-09-01
Description

Mars Incorporated acquired Germany-based SYNLAB.vet GmbH to strengthen its position in the European veterinary laboratory market and expand global diagnostics offerings.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-06-01
Description

Mars, Incorporated acquired Heska Corporation for approximately $1.3 billion to expand its pet health diagnostics capabilities. Heska specializes in advanced veterinary diagnostics including Element series analyzers, Nu.Q cancer screening, and telecytology solutions now integrated into Antech's portfolio.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2022-05-09
Description

ARCHIMED's MED II fund sold point-of-care diagnostics company EUROLyser to Antech Diagnostics, a subsidiary of Mars Veterinary Health. EUROLyser specialized in point-of-care diagnostic equipment including the Eurolyser Cube platform now offered under Antech's in-house diagnostics portfolio.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

PetDx offers OncoK9 liquid biopsy test for canine cancer detection using next-generation sequencing, directly competing with Antech's Nu.Q cancer screening platform in the emerging veterinary oncology diagnostics category.

TypeBroad incumbent
Description

Virbac is a global animal health company offering veterinary diagnostics (including allergy and infectious disease testing) as part of a broader pharmaceutical and nutrition portfolio, competing in select segments like allergy testing against Allercept.

TypeEmerging player
Description

Basepaws, acquired by Zoetis, offers feline and canine genetic and oral microbiome testing; competes in the broader pet health diagnostics space with Antech's advanced molecular and screening panels, particularly for preventive care programs.

TypeBroad incumbent
Description

Zoetis is the largest animal health company globally and competes via its Vetscan in-house diagnostic suite (chemistry, hematology, urinalysis) and reference lab offerings through Vetscan Imagyst AI; broader portfolio includes pharmaceuticals and vaccines beyond diagnostics.

TypeRegional player
Description

SYNLAB is Europe's largest medical diagnostic services provider with veterinary diagnostics (SYNLAB.vet) now acquired by Mars; competes in European reference lab testing with similar clinical pathology and microbiology offerings to Antech in that geography.

TypeEmerging player
Description

Embark offers direct-to-consumer and veterinarian-channel canine genetic testing and breed identification, an adjacent but distinct category from Antech's clinical pathology focus; both compete for veterinary practice attention and shelf space for advanced testing services.

TypeRegional player
Description

Cerba HealthCare is a European clinical pathology and specialty diagnostics provider also acquired by Mars in 2025; competes with Antech's European operations in clinical pathology and reference laboratory services across France, Belgium, Italy, and other European markets.

TypeOthers
Description

Volition is the inventor and licensor of the Nu.Q nucleosome-based cancer screening technology used in Antech's canine cancer diagnostics; functions as a technology/IP partner rather than direct competitor, though Volition is commercializing competing veterinary cancer screening tests in some markets.

TypeDirect peer
Description

IDEXX is the dominant scaled competitor in veterinary reference laboratory services and in-house diagnostic analyzers (VetLab, Catalyst, ProCyte, SediVue), directly competing with Antech across chemistry, hematology, infectious disease, and reference lab send-out services in North America.

TypeDirect peer
Description

Heska was a direct competitor in in-house veterinary diagnostic analyzers and allergy testing before being acquired by Mars in 2023 and integrated into Antech; products (Element series, Nu.Q, HeskaView) now operate within the Antech portfolio but historically competed head-to-head.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Antech Diagnostics

Veterinary Diagnostic Laboratory Servicesantechdiagnostics.com

Antech Diagnostics is a privately held US veterinary diagnostics company and subsidiary of Mars, Incorporated, operating North America's largest veterinary reference lab network. It serves veterinary practices with reference lab testing, in-house analyzers, Sound imaging equipment, AI radiology interpretation, and specialist consultation.

What Antech Diagnostics does

Antech Diagnostics, Inc. is a US-based veterinary diagnostics company and wholly-owned subsidiary of Mars, Incorporated, operating within Mars Petcare's Science & Diagnostics division. The company is positioned as North America's largest veterinary reference laboratory network and serves veterinary practices across the United States, Canada, the United Kingdom, and additional European markets. Its offering is a fully integrated diagnostic ecosystem combining reference laboratory send-out testing, in-house bench-top and handheld analyzers (Element series, trūRapid, Eurolyser Cube, scil Vet abc Plus+), Sound-branded imaging equipment (ultrasound, digital radiography, CT, C-Arm, laser therapy), AI-powered radiology interpretation (RapidRead, RapidRead Dental), proprietary specialty tests (KeyScreen GI Parasite PCR, CADET BRAF, Nu.Q, Allercept, FIRSTract), and access to 130+ board-certified pathologists and 50+ specialists for consultation.

The business operates across multiple revenue streams: recurring reference lab per-test fees (with completion and recheck codes), hardware sales plus consumables for in-house analyzers, imaging equipment sales and service subscriptions, and Allercept custom immunotherapy formulations. Distribution is direct-to-practice via dedicated phone support, account managers, and the HealthTracks cloud platform for ordering, results, and patient data management. Product innovation is concentrated in AI-enabled imaging interpretation and proprietary molecular diagnostics, with sustained launch cadence through 2025 and into 2026.

The company is privately held and does not disclose revenue. Its strategic trajectory has been defined by a series of parent-funded acquisitions — EUROLyser (2022), Heska Corporation at approximately $1.3 billion (2023), SYNLAB.vet GmbH (2023), and Cerba HealthCare (2025) — alongside geographic expansion into the UK and Europe, positioning Mars Science & Diagnostics as a global consolidator in veterinary laboratory services and in-clinic diagnostics.

Antech Diagnostics firmographics

Firmographics
Name
Antech Diagnostics
Legal name
Antech Diagnostics, Inc
Website
https://antechdiagnostics.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Antech Diagnostics is a privately held US veterinary diagnostics company and subsidiary of Mars, Incorporated, operating North America's largest veterinary reference lab network. It serves veterinary practices with reference lab testing, in-house analyzers, Sound imaging equipment, AI radiology interpretation, and specialist consultation.
Ownership category
akta.pro rank

Antech Diagnostics industry classification

Industry
Product category
Veterinary Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Veterinary Services (54194), Analytical Laboratory Instrument Manufacturing (334516)
SIC
Services-Medical Laboratories (8071), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)
akta.pro secondary industries
Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI), Veterinary Anatomic Pathology (Histopathology & Cytology) (HLAMADAB), Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC), Imaging/Lab Integration & Results Management (PACS, LIS Connectivity, Reporting) (HLAMAGAK)

Keywords

  • Veterinary reference laboratory
  • Veterinary diagnostic testing
  • Animal health diagnostics
  • Veterinary imaging equipment
  • In-clinic diagnostic analyzers

Where Antech Diagnostics is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Antech Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Reference Laboratory Testing Services: Send-out diagnostic testing services to veterinary practices across North America. Provides comprehensive testing including chemistry, hematology, pathology, microbiology, molecular diagnostics, and specialized panels. Revenue generated through per-test fees with completion codes and recheck codes at reduced pricing for ongoing patient monitoring.
  2. In-House Diagnostic Equipment Sales: Sale of bench-top and handheld analyzers including Element series (DCX, HT5+, HT5, i+, POC), HeskaView telecytology systems, trūRapid rapid tests, and related consumables. Equipment sold to veterinary clinics for in-practice testing with ongoing consumable revenue.
  3. Imaging Equipment and Services: Sale and service of diagnostic imaging equipment including digital radiography, ultrasound, CT, and therapeutic lasers through Sound brand. Additionally provides teleradiology and RapidRead AI interpretation services as ongoing subscription.
  4. Allercept Immunotherapy Products: Custom immunotherapy treatments (shots and drops) manufactured based on individual patient allergy testing results. Revenue from allergen-specific immunotherapy formulations for dogs, cats, and horses.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Antech Diagnostics product offering

Product offering

Core offering

Antech Diagnostics operates North America's largest veterinary reference laboratory network, providing send-out diagnostic testing across chemistry, hematology, pathology, microbiology, molecular diagnostics, cancer screening, and allergy panels. The company complements this with a portfolio of in-clinic diagnostic analyzers and rapid tests (Element series, trūRapid series, Eurolyser Cube), AI-powered imaging interpretation (RapidRead and RapidRead Dental), Sound-branded imaging equipment, board-certified specialist consultation across nine disciplines, and the HealthTracks cloud platform for test ordering and results delivery.

Differentiator

Problem solved

Functional benefit

Brands

  • RapidRead™: AI-powered radiology interpretation tool for veterinary radiographs, including tooth-by-tooth dental analysis.
  • PennHIP™
  • Element™ Series
  • KeyScreen™
  • Accuplex™
  • Allercept™
  • CADET™ BRAF
  • Nu.Q®
  • trūRapid™
  • HealthTracks™
  • HeskaView™
  • Loved for Life by Antech™
  • Eurolyser Cube™
  • scil Vet abc Plus+

Products and services

  • Reference Laboratory Testing Services North America's largest veterinary reference laboratory network providing send-out diagnostic testing including chemistry, hematology, pathology, microbiology, molecular diagnostics, and specialized panels to veterinary practices with 24-48 hour turnaround for most tests.
  • KeyScreen GI Parasite PCR Cutting-edge gastrointestinal parasite PCR test using proprietary technology to identify parasite genetic material in fecal samples from dogs and cats, detecting 20 intestinal parasites, benzimidazole resistance in hookworms, and zoonotic potential of Giardia.
  • Accuplex Multiplexed canine vector-borne disease screening test detecting heartworm antigen and antibodies for tick-borne diseases, with results typically available by 8:00 am the next day.
  • Canine Cancer Diagnostics (CADET BRAF and Nu.Q) Reference laboratory cancer screening tests including CADET BRAF mutation detection for early canine bladder/prostate cancer (TCC/UC) and Nu.Q measurement of plasma nucleosome concentration for lymphoma and hemangiosarcoma detection.
  • Allercept Allergy Testing and Immunotherapy Serum allergy testing using patented IgE detection technology sensitive to 10 picograms, combined with custom immunotherapy treatments (shots and drops) manufactured for individual patients with 50-80% positive response rates reported.
  • Element Series In-House Diagnostic Analyzers Bench-top and handheld in-clinic diagnostic analyzers including Element i+, DCX, HT5+, HT5, DC5X, AIM, COAG+, and POC for chemistry, hematology, blood gas, and coagulation testing, plus Element i+ SDMA testing for kidney function assessment added in January 2026.
  • trūRapid In-House Test Series Rapid in-clinic immunodiagnostic tests including trūRapid FOUR for heartworm antigen, Lyme C6 antibody, Anaplasma, and Ehrlichia; plus Heartworm, HW/Lyme, and FIV/FeLV tests with room temperature storage and no refrigeration required.
  • Sound Imaging Equipment Diagnostic imaging equipment line sold under the Sound brand including digital radiography, ultrasound, CT, C-arm, and therapeutic laser systems for veterinary practices, with installation, training, and demo support.
  • RapidRead AI Radiology Interpretation AI-powered radiology interpretation service combining computer vision analysis with board-certified veterinary radiologist overread for enhanced diagnostic confidence on general radiographs.
  • RapidRead Dental AI-powered computer vision tool delivering tooth-by-tooth analysis of veterinary intraoral dental radiographs in approximately 10 minutes, with a feline-specific version launched January 2026 addressing small tooth size and high tooth resorption prevalence.
  • PennHIP Hip joint laxity measurement service used to estimate risk of canine osteoarthritis, with online training and a locator service for PennHIP-certified veterinarians.
  • HeskaView Telecytology Telecytology service providing digital cytology consultations and practice information management system (PIMS) software solutions for veterinary practices.
  • HealthTracks Platform Cloud-based platform for ordering diagnostic tests, accessing laboratory and imaging results, and managing patient data, available via web and mobile with self-service onboarding for veterinary practices.
  • Consultation Services Peer-to-peer expert medical consultation services from 50+ board-certified specialists across nine disciplines, providing veterinary practices with specialist support on complex cases.
  • Loved for Life by Antech Preventive care wellness program offering comprehensive diagnostic profiles designed to support lifelong pet health monitoring.

Quantifiable outcome

  • 98% overall agreement with reference lab methods for trūRapid FOUR vector-borne disease screening
  • +4 more outcomes

Companies that use Antech Diagnostics

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Antech Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature10 records

Antech Diagnostics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • Vet Set GominorGTM or Marketing Partner · 21 April 2026Antech launched the Antech Veterinary Futures Scholarship in partnership with Vet Set Go to support aspiring veterinary professionals. The scholarship invests in students to ensure pets receive quality care, coinciding with World Veterinary Day 2026.
  • Cerba HealthCarecoreOEM/ Whitelabel/ Licensing Partner · 1 January 2025Mars acquisitions of Cerba HealthCare to consolidate presence in clinical pathology markets as part of Mars Science & Diagnostics expansion.
  • SYNLAB.vet GmbHcoreOEM/ Whitelabel/ Licensing Partner · 1 September 2023Mars Incorporated acquired Germany-based SYNLAB.vet GmbH to strengthen its position in the European veterinary laboratory market and expand global diagnostics offerings.
  • Heska CorporationcoreOEM/ Whitelabel/ Licensing Partner · 1 June 2023Mars, Incorporated acquired Heska Corporation for approximately $1.3 billion to expand its pet health diagnostics capabilities. Heska specializes in advanced veterinary diagnostics including Element series analyzers, Nu.Q cancer screening, and telecytology solutions now integrated into Antech's portfolio.
  • EUROLysercoreOEM/ Whitelabel/ Licensing Partner · 9 May 2022ARCHIMED's MED II fund sold point-of-care diagnostics company EUROLyser to Antech Diagnostics, a subsidiary of Mars Veterinary Health. EUROLyser specialized in point-of-care diagnostic equipment including the Eurolyser Cube platform now offered under Antech's in-house diagnostics portfolio.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Antech Diagnostics competitors and assessment

Company assessment

Emerging players

  • PetDx: PetDx offers OncoK9 liquid biopsy test for canine cancer detection using next-generation sequencing, directly competing with Antech's Nu.Q cancer screening platform in the emerging veterinary oncology diagnostics category.
  • Basepaws (Zoetis): Basepaws, acquired by Zoetis, offers feline and canine genetic and oral microbiome testing; competes in the broader pet health diagnostics space with Antech's advanced molecular and screening panels, particularly for preventive care programs.
  • Embark Veterinary: Embark offers direct-to-consumer and veterinarian-channel canine genetic testing and breed identification, an adjacent but distinct category from Antech's clinical pathology focus; both compete for veterinary practice attention and shelf space for advanced testing services.

Broad incumbents

  • Virbac: Virbac is a global animal health company offering veterinary diagnostics (including allergy and infectious disease testing) as part of a broader pharmaceutical and nutrition portfolio, competing in select segments like allergy testing against Allercept.
  • Zoetis: Zoetis is the largest animal health company globally and competes via its Vetscan in-house diagnostic suite (chemistry, hematology, urinalysis) and reference lab offerings through Vetscan Imagyst AI; broader portfolio includes pharmaceuticals and vaccines beyond diagnostics.

Regional players

  • SYNLAB: SYNLAB is Europe's largest medical diagnostic services provider with veterinary diagnostics (SYNLAB.vet) now acquired by Mars; competes in European reference lab testing with similar clinical pathology and microbiology offerings to Antech in that geography.
  • Cerba HealthCare: Cerba HealthCare is a European clinical pathology and specialty diagnostics provider also acquired by Mars in 2025; competes with Antech's European operations in clinical pathology and reference laboratory services across France, Belgium, Italy, and other European markets.

Others

  • Volition Veterinary: Volition is the inventor and licensor of the Nu.Q nucleosome-based cancer screening technology used in Antech's canine cancer diagnostics; functions as a technology/IP partner rather than direct competitor, though Volition is commercializing competing veterinary cancer screening tests in some markets.

Direct peers

  • IDEXX Laboratories: IDEXX is the dominant scaled competitor in veterinary reference laboratory services and in-house diagnostic analyzers (VetLab, Catalyst, ProCyte, SediVue), directly competing with Antech across chemistry, hematology, infectious disease, and reference lab send-out services in North America.
  • Heska Corporation: Heska was a direct competitor in in-house veterinary diagnostic analyzers and allergy testing before being acquired by Mars in 2023 and integrated into Antech; products (Element series, Nu.Q, HeskaView) now operate within the Antech portfolio but historically competed head-to-head.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Antech Diagnostics social profiles

Digital presence

Antech Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Antech Diagnostics leadership team

Management profile

Number of profiles

Profiles8 records

Antech Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Antech Diagnostics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Antech Diagnostics

What does Antech Diagnostics do?

Antech Diagnostics operates North America's largest veterinary reference laboratory network, providing send-out diagnostic testing across chemistry, hematology, pathology, microbiology, molecular diagnostics, cancer screening, and allergy panels. The company complements this with a portfolio of in-clinic diagnostic analyzers and rapid tests (Element series, trūRapid series, Eurolyser Cube), AI-powered imaging interpretation (RapidRead and RapidRead Dental), Sound-branded imaging equipment, board-certified specialist consultation across nine disciplines, and the HealthTracks cloud platform for test ordering and results delivery.

Is Antech Diagnostics a public or private company?

Antech Diagnostics is a private company. It is classified as corporate owned and is currently operating.

When was Antech Diagnostics founded?

Antech Diagnostics was founded in 1994. It employs 1,001 to 5,000 people.

Where is Antech Diagnostics based?

Antech Diagnostics is headquartered in Irvine, United States, in the North America region.

How does Antech Diagnostics make money?

Four revenue lines are on record. Reference Laboratory Testing Services are the primary driver. The others are in-House Diagnostic Equipment Sales, imaging Equipment and Services and allercept Immunotherapy Products.

Who are Antech Diagnostics's main competitors?

Emerging players on record are PetDx, Basepaws (Zoetis) and Embark Veterinary. Broad incumbents are Virbac and Zoetis. Regional players are SYNLAB and Cerba HealthCare. Volition Veterinary is listed as an others. Direct peers are IDEXX Laboratories and Heska Corporation.

Does Antech Diagnostics have an API?

No public API is recorded for Antech Diagnostics.

What industry is Antech Diagnostics in?

Antech Diagnostics's product category is Veterinary Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAMADAA, Reference Laboratory Testing (Clinical Pathology & Chemistry), with a secondary code of HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageAntech™ Introduces trūRapid™ Reader in North America to Support trūRapid PortfolioAntech launched the trūRapid Reader in North America, a portable device that captures timed images of trūRapid test results at the 10-minute mark. The device stores about 200 images, requires no routine maintenance, and integrates with HealthTracks. The company cites growing momentum with the trūRapid portfolio.Pulse 2.0Wonderdog Launches With $5 Million Pre-Seed To Bring At-Home Blood Testing And AI Health Intelligence To Preventive Dog CareWonderdog, a preventive health platform for dogs, has launched publicly with $5 million in pre-seed funding led by WndrCo and Maveron, offering at-home blood diagnostics measuring over 40 biomarkers combined with an AI-powered health tracking app called Spark. The company operates a membership model ($249-$448 annually) where licensed veterinary technicians perform at-home blood draws, samples are analyzed by Antech reference laboratory, and results are delivered through the app within three business days. The service is currently available in Manhattan, Brooklyn, and Los Angeles County, with expansion planned to Phoenix and Miami.Business Wire BlogWonderdog Launches a New Era of Preventive Health for DogsWonderdog, a preventive health platform for dogs, launched today offering at-home blood diagnostics measuring over 40 biomarkers combined with AI-powered health tracking, with samples analyzed by Antech reference laboratories. The company has raised $5 million in pre-seed funding led by venture capital firms WndrCo and Maveron. Membership plans start at $249 annually for one at-home blood draw and are currently available in Manhattan, Brooklyn, and Los Angeles County with plans to expand to Phoenix and Miami.FinancialContent Business PageWonderdog Launches a New Era of Preventive Health for DogsWonderdog has launched a preventive health platform for dogs combining at-home blood diagnostics measuring over 40 biomarkers with AI-powered health tracking, backed by $5 million in pre-seed funding led by WndrCo and Maveron. The service, currently available in Manhattan, Brooklyn, and Los Angeles County with planned expansion to Phoenix and Miami, analyzes blood samples through Antech reference laboratories and delivers results via a mobile app featuring an AI companion named Spark. Wonderdog founders Jeff Safenowitz and Patrick Riley previously co-founded Barkbus, the nation's largest mobile dog grooming business.openPR.comLeading Companies Advancing Innovation and Growth in the Veterinary Laboratory Testing Services MarketThe veterinary laboratory testing services market is projected to reach $38.14 billion by 2030, growing at a compound annual growth rate of 8.1%, driven by advancements in molecular diagnostics, immunodiagnostics, and integrated testing platforms. In April 2023, Mars, Incorporated acquired Heska Corporation, a specialist in advanced veterinary diagnostics, to expand its pet care science and diagnostics portfolio globally. In November 2023, Antech, operating under Mars Science & Diagnostics, launched its first full-service veterinary diagnostics platform in the UK, featuring advanced imaging, telemedicine, and DNA-based parasite screening services.openPR.comCompetitive Landscape: Key Market Leaders and Rising Participants in the Artificial Intelligence (AI)-Driven Veterinary Diagnostics IndustryThe AI-powered veterinary diagnostics market is projected to reach $4.85 billion by 2030, growing at a compound annual growth rate of 20.0%, driven by AI-enabled diagnostic software, wearable monitoring devices, tele-veterinary services, and big data analytics. In September 2023, Mars Incorporated acquired Germany-based SYNLAB.vet GmbH to strengthen its position in the European veterinary laboratory market and expand its global diagnostics offerings. In May 2025, Antech Diagnostics Inc. launched RapidRead Dental, an AI-enabled radiology interpretation tool for veterinary dental images that delivers tooth-by-tooth analysis in approximately 10 minutes.openPR.comVeterinary Diagnostics Market to Reach $5.36 Billion by 2030 Driven by Rising Animal Health AwarenessMarketsandMarkets published a market research report projecting the global veterinary diagnostics market will grow from USD 3.68 billion in 2025 to USD 5.36 billion by 2030, representing a compound annual growth rate of 7.8%. The report segments the market by technology, product, animal type, application, end user, and region, identifying consumables, companion animals, infectious disease testing, and the Asia Pacific region as leading growth drivers. Key players listed in the report include IDEXX Laboratories, Zoetis Services LLC, Thermo Fisher Scientific Inc., Antech Diagnostics, and bioMerieux.YahooAntech™ launches next-generation diagnostic innovations to advance clinical decision-making at VMX 2026Antech announced the launch of RapidRead Dental for Feline, an AI-powered dental radiograph analysis solution built specifically for cats, and the addition of SDMA testing to its Element i+ in-house diagnostic platform, both being highlighted at VMX 2026. RapidRead Dental delivers expert-level analysis in under five minutes and was developed specifically for feline dentistry rather than adapted from canine radiographs, addressing challenges like small tooth size and high prevalence of tooth resorption in cats. The SDMA addition provides quantitative kidney function results in under three minutes, expanding Antech's in-house diagnostics portfolio with immediate, sensitive assessment capabilities.YahooArtificial Intelligence (AI)-Powered Veterinary Diagnostics Research Report 2025: Market to Reach $4.05 Billion by 2029 Amid Surge in Precision Animal Healthcare - Global Long-term Forecast to 2034The global AI-powered veterinary diagnostics market is projected to grow from $1.94 billion in 2025 to $4.05 billion by 2029, driven by rising pet ownership and demand for precision animal healthcare. Key industry players such as Antech Diagnostics and Mars Incorporated are advancing the sector through new AI diagnostic tools and strategic acquisitions like SYNLAB.vet. Despite this growth, the industry faces operational cost increases due to rising U.S. tariffs and trade tensions.EIN PresswireArtificial Intelligence (AI)-Powered Veterinary Diagnostics Market to Exceed US $4.05 Billion by 2029, with 20.2% CAGRThe Business Research Company has published market research forecasting that the global AI-powered veterinary diagnostics market will grow from $1.61 billion in 2024 to $4.05 billion by 2029, representing a compound annual growth rate of 20.2%. Key growth drivers include rising pet ownership, increased spending on animal health, demand for advanced diagnostic tools, and the growing prevalence of animal diseases. Major companies identified in the market include Zoetis Inc., Antech Diagnostics Inc., and smaXtec animal care technology GmbH, with Antech notably launching its RapidRead Dental AI radiology interpretation tool in May 2025.